ESTRO 2024 - Abstract Book

S2798

Interdisciplinary - Health economics & health services research

ESTRO 2024

Conclusion:

The results demonstrated suboptimal use of multiparametric MRI at the time of initial diagnosis and staging of prostate cancer. Additionally, the results indicate suboptimal use of bone scans for staging of patients with intermediate-risk and high-risk disease. A minority of participants reported inappropriate management of localized intermediate- and high-risk prostate cancer. Furthermore, limited access to brachytherapy, robotic prostatectomy, and to a lesser extent advanced radiotherapy techniques was found. This study could guide future MENA prostate cancer policies and direct funds.

Keywords: prostate cancer, the Middle East and North Africa

References:

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin [Internet]. CA Cancer J Clin; 2021 May [cited 2023 Oct 25];71(3):209 – 49. Available from: https://pubmed.ncbi.nlm.nih.gov/33538338/ 2. Prostate cancer risk groups and the Cambridge Prognostic Group (CPG) | Cancer Research UK [Internet]. [cited 2023 Oct 25]. Available from: https://www.cancerresearchuk.org/about-cancer/prostate cancer/stages/cambridge-prognostic-group-cpg